BFM
CPIX icon

Boothbay Fund Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Boothbay Fund Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$729K Sell
112,544
-15,150
-12% -$72.6K 0.01% 1280
2026
Q1 		$415K Sell
127,694
-813
-0.6% -$3.13K 0.01% 1443
2025
Q4 		$511K Sell
128,507
-39,625
-24% -$117K 0.01% 1130
2025
Q3 		$525K Sell
168,132
-12,097
-7% -$40.2K 0.01% 1130
2025
Q2 		$604K Sell
180,229
-43,569
-19% -$206K 0.01% 847
2025
Q1 		$947K Buy
+223,798
New +$928K 0.02% 653

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Boothbay Fund Management's CPIX Position: Q2 2026 in Review

Boothbay Fund Management reduced its Cumberland Pharmaceuticals (CPIX) stake by 12% in Q2 2026, selling an estimated $72.6K and leaving 112,544 shares worth $729K. The position accounts for 0.01% of the portfolio, ranked #1280.

Boothbay Fund Management first reported a position in CPIX in Q1 2025 and has held it in 6 quarters since. The position peaked at $947K in Q1 2025. 32 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • Boothbay Fund Management held 112,544 shares of Cumberland Pharmaceuticals worth $729K as of Q2 2026.
  • Boothbay Fund Management sold 15,150 Cumberland Pharmaceuticals shares in Q2 2026, an estimated $72.6K.
  • Cumberland Pharmaceuticals made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1280 holding.
  • Boothbay Fund Management first reported a position in Cumberland Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Boothbay Fund Management's Cumberland Pharmaceuticals position peaked at $947K in Q1 2025.
  • 32 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.